Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Most Medicare Part D plans offer coverage for Jardiance, a drug used to treat heart failure and type 2 diabetes. That said, coverage depends on whether the drug is included in the specific plan’s ...

The Food and Drug Administration approved Eli Lilly’s Jardiance (empagliflozin) for treating adults with chronic kidney disease (CKD) on Friday morning. The agency approved 10 mg tablets of Jardiance ...

FRANKFURT, Nov 4 (Reuters) - Boehringer Ingelheim and Eli Lilly (LLY.N), opens new tab said their diabetes drug Jardiance was shown to slow the progression of chronic kidney disease (CKD), as they ...

Heart failure and chronic kidney disease often go hand in hand. And when they do, the risk of death and hospitalization increase. A new analysis from Eli Lilly and Boehringer Ingelheim on their ...